Fetal cardiac scanning today

Prenatal Diagnosis

Volumn 30, Issue 7, 2010, Pages 639-643

  Allan, Lindsey ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Congenital heart disease; Fetal echocardiography; Nuchal translucency; Prenatal diagnosis

Indexed keywords

ANTIARRHYTHMIC AGENT;

CONGENITAL HEART DISEASE; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FETUS HEART; GESTATIONAL AGE; HUMAN; NUCHAL TRANSLUCENCY MEASUREMENT; POSTNATAL DEVELOPMENT; PREGNANCY TERMINATION; PRENATAL CARE; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; ECHOGRAPHY; FEMALE; FETUS; FETUS ECHOGRAPHY; HEART DEFECTS, CONGENITAL; NEWBORN; PREGNANCY; PROCEDURES; STANDARDS;

FEMALE; FETAL HEART; FETUS; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; PREGNANCY; ULTRASONOGRAPHY, PRENATAL;

EID: 77954128006     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2540     Document Type: Review

References (44)

1. Allan LD, Apfel HD, Printz BF. 1998. Outcome after prenatal diagnosis of the hypoplastic left heart syndrome. Heart 79: 371-373.
2. Allan LD, Ferguson-Smith MA, Donald I, Sweet EM, Gibson EM. 1973. Amniotic fluid alpha-fetoprotein: antenatal diagnosis of spina bifida. Lancet 11(7828): 522-550.
3. Allan LD, Sharland GK, Milburn A, et al. 1994. Prospective diagnosis of 1,006 consecutive cases of congenital heart disease in the fetus. J Am Coll Cardiol 23: 1452-1458.
4. Allan LD, Tynan MJ, Campbell S, Wilkinson JL, Anderson RH. 1980. Echocardiographic and anatomical correlates in the fetus. Br Heart J 44: 444-451.
5. Atzei A, Gajewska K, Huggon IC, Allan L, Nicolaides KH. 2005. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype. Ultrasound Obstet Gynecol 26: 154-157.
6. Ballweg JA, Wernovsky G, Gaynor JW. 2007. Neurodevelopmental outcomes following congenital heart surgery. Pediatr Cardiol 28: 126-133.
7. Benacerraf B, Gelman R, Frigoletto FD. 1987. Sonographic identification of secondtrimester fetuses with Down's syndrome. N Engl J Med 317: 1371-1374. (Pubitemid 18052343)
8. Bonnet D, Coltri A, Butera G, et al. 1999. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 99: 916-918. (Pubitemid 29094306)
9. Brock DJ, Sutcliffe RG. 1972. Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida. Lancet 2: 197-199.
10. Bull C. British Paediatric Cardiac Association. 1999. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. Lancet 35(7770): 1242-1247.
11. Corya BC, Rasmussen S, Knoebel SB, Feigenbaum H. 1977. M-mode echocardiography in evaluating left ventricular function and surgical risk in patients with coronary artery disease. Chest 72: 181-185.
12. Donald I. 1969. Ultrasonics in diagnosis (Sonar). Proc R Soc Med 62: 442-446.
13. Feigenbaum H. 1996. Evolution of echocardiography. Circulation 93: 1321-1327.
14. Franklin O, Burch M, Manning N, Sleeman K, Gould S, Archer N. 2002. Prenatal diagnosis of coarctation of the aorta improves survival and reduces morbidity. Heart 87: 67-69.
15. Friedman DM, Kim MY, Copel JA, Llanos C, Davis C, Buyon JP. 2009. Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study. Am J Cardiol 103: 1102-1106.
16. Garne E, Loane M, Dolk H, et al. 2005. Prenatal diagnosis of severe structural congenital malformations in Europe. Ultrasound Obstet Gynecol 25: 6-11.
17. Griffith JM, Henry WL. 1974. A sector scanner for real time two-dimensional echocardiography. Circulation 49: 1147-1152.
18. Huggon IC, Turan O, Allan LD. 2004. Doppler assessment of cardiac function at 11-14 weeks' gestation in fetuses with normal and increased nuchal translucency. Ultrasound Obstet Gynecol 24: 390-398.
19. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH. 1999. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ 318: 81-85.
20. Ionescu-Ittu R, Marelli AJ, Mackie AS, Pilote L. 2009. Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada. BMJ 338: 1673.
21. Jaeggi ET, Nii M. 2005. Fetal brady- and tachyarrhythmias: new and accepted diagnostic and treatment methods. Semin Fetal Neonatal Med 10: 504-514.
22. King DL. 1973. Real-time cross-sectional ultrasonic imaging of the heart using a linear array multi-element transducer. J Clin Ultrasound 1: 196-201.
23. Kirwan D. 2010. The NHS Fetal Anomaly Screening Programme (NHS FASP). 2010. 18 + 0 to 20 + 6 Weeks Fetal Anomaly Scan National Standards and Guidance for England. http://fetalanomaly.screening.nhs.uk/standardsandpolicies. [Accessed on 2010].
24. Kleinman CS, Hobbins JC, Jaffe CC, Lynch DC, Talner NS. 1980. Echocardiographic studies of the human fetus: prenatal diagnosis of congenital heart disease and cardiac dysrhythmias. Pediatrics 65: 1059-1067.
25. Kumar RK, Newburger JW, Gauvreau K, Kamenir SA, Hornberger LK. 1999. Comparison of outcome when hypoplastic left heart syndrome and transposition of the great arteries are diagnosed prenatally versus when diagnosis of these two conditions is made only postnatally. Am J Cardiol 83: 1649-1653.
26. Lange LW, Sahn DJ, Allen HD, Goldberg SJ, Anderson C, Giles H. 1980. Qualitative realtime cross-sectional echocardiographic imaging of the human fetus during the second half of pregnancy. Circulation 62: 799-806.
27. Makrydimas G, Sotiriadis A, Huggon IC, et al. 2005. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centres. Am J Obstet Gynecol 192: 89-95.
28. Matsui H, Mellander M, Roughton M, Jicinska H, Gardiner HM. 2008. Morphological and physiological predictors of fetal aortic coarctation. Circulation 118: 1793-1801.
29. Maxwell D, Allan L, Tynan MJ. 1991. Balloon dilatation of the aortic valve in the fetus: a report of two cases. Br Heart J 65: 256-258.
30. McCrindle BW, Williams RV, Mitchell PD, et al. 2006. Relationship of patient and medical characteristics to health status in children and adolescents after the Fontan procedure. Circulation 113: 1123-1129.
31. McElhinney DB, Marshall AC, Wilkins-Haug LE, et al. 2009. Predictors of technical success and postnatal biventricular outcome after in utero aortic valvuloplasty for aortic stenosis with evolving hypoplastic left heart syndrome. Circulation 120: 1482-1490.
32. Michailidis GD, Economides DL. 2001. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol 17: 102-105.
33. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. 1992. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. Br Med J 304: 867-869.
34. Poon LC, Huggon IC, Zidere V, Allan LD. 2007. Tetralogy of Fallot in the fetus in the current era. Ultrasound Obstet Gynecol 29: 625-627.
35. Rasiah SV, Ewer AK, Miller P, Wright JG, Tonks A, Kilby MD. 2008. Outcome following prenatal diagnosis of complete atrioventricular septal defect. Prenat Diagn 28: 95-101.
36. Sahn DJ, Allen HD, Goldberg SJ, Soling R, Meyer RA. 1975. Pediatric echocardiography: a review of its clinical utility. J Pediatr 87: 335-352.
37. Selamet Tierney ES,Wald RM, McElhinney DB, et al. 2007. Changes in left heart hemodynamics after technically successful in-utero aortic valvuloplasty. Ultrasound Obstet Gynecol 30: 715-720.
38. Sharland GK, Allan LD. 1992. Screening for congenital heart disease prenatally. Results of a 2 1/2-year study in the South East Thames Region. Br J Obstet Gynaecol 99: 220-225.
39. Simpson JM, Sharland GK. 1998. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart 79: 576-581.
40. Tegnander E, Eik-Nes SH, Johansen OJ, Linker DT. 1995. Prenatal detection of heart defects at the routine fetal examination at 18 weeks in a non-selected population. Ultrasound Obstet Gynecol 5: 372-380.
41. Tworetzky W, McElhinney DB, Marx GR, et al. 2009. In utero valvuloplasty for pulmonary atresia with hypoplastic right ventricle: techniques and outcomes. Pediatrics. [E-pub ahead of print].
42. Vida VL, Bacha EA, Larrazabal A, et al. 2007. Hypoplastic left heart syndrome with intact or highly restrictive atrial septum : surgical experience from a single center. Ann Thorac Surg 84: 581-585.
43. Vogel M, Sharland GK, McElhinney DB, et al. 2009. Prevalence of increased nuchal translucency in fetuses with congenital cardiac disease and a normal karyotype. Cardiol Young 19: 441-445.
44. Westin M, Saltvedt S, Almström H, Grunewald C, Valentin L. 2007. By how much does increased nuchal translucency increase the risk of adverse pregnancy outcome in chromosomally normal fetuses? A study of 16,260 fetuses derived from an unselected pregnant population. Ultrasound Obstet Gynecol 29: 150-158.